Menu

  1. Home
  2.  / 
  3. Free Paper, Vitreo Retinal Diseases - IV + Finals
  4.  / 
  5. FP0587 : Retrospective analysis of previtrectomy (PPV)Ranibizumab(IVR) for diabetic vitreous hemorrhage(DVH).

Share this post

Chief & Presenting Author: Dr.Rituraj Videkar

Co Author(s): Dr.Rituraj Videkar

Abstract

Methods:40 eyes of DVH analyzed. All eyes underwent complete ophthalmic examination(COE), ultrasound B scan examination(USG) and IVR prior to PPV. DVH with attached retina confirmed on USG post IVR 3-30 days prior to PPV were included.Eyes with uveitis, glaucoma, preop or postop RD, nystagmus, optic neuropathy, follow up less than 3 months excluded.Routine diabetic PPV was performed .Combined phacoemulsification with IOL performed for phakic(PH) eyes. Postop COE including OCT for optic disc (OCT RNFL) and macula performed. Endodiathermy application (ED),OCT RNFL, rebleed(RB) rates post PPV analysed. RB is recurrence of VH between 4 weeks to 12 weeks post PPV. Results: 40 eyes received IVR ,15 patients showed resolution of VH.2 patients did not have adequate follow up. 23 patients analysed.7 were PH and 16 were pseudophakic (PPH).1/23 patients had RB,5/23 patients had ED applications. Average OCT RNFL thickness:90.71 microns average preop vision:HMCF average postop vision:0.254.